Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
AACR report highlights progress in preventing and treating cancer—including 27 new drug approvals last year—but disparities persist.
Changing gut bacteria to improve treatment response may be the next frontier in immunotherapy.
A three-pronged approach could offer hope for people with hard-to-treat advanced pancreatic cancer.
Additional research is required to determine the basis for these racial disparities.
Women who had breast-conserving surgery rather than mastectomy report better quality of life.
Lung, colorectal and liver cancer deaths were significantly higher among third-generation U.S.-born Latinos.
Study supports incorporating supervised exercise programs into breast cancer treatment guidelines.
Tailored feedback at colorectal cancer screenings increased preventive lifestyle behaviors.
Shared database helps find treatment for cancers too rare to have their own clinical trials.
Customized immunotherapy targets receptor found in some breast, colorectal, lung, ovarian, prostate and gastroesophageal cancers.
Immunotherapy worked better than chemotherapy as first-line treatment for people with a favorable biomarker.
More than 300 organizations call for more funding for the National Institutes of Health.
FDA approved 22 new cancer therapies or indications between August 2017 and July 2018.
NCI director Norman Sharpless shares his vision at American Association for Cancer Research annual meeting.
Immunotherapy lowered the likelihood of relapse after surgery.
Dream Team aims to replace “watch and wait” with effective treatments.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.